PCOS diagnostic Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	165 Pages	Coherent Market Insights	June, 2023	CMI18049155

Best Price Guarantee
Price	from $4,500
Length	165 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049155

PCOS diagnostic Market, By Type of Diagnostic Test (Hormone Testing, Imaging Tests, Blood Tests, Other Tests), By End-User (Hospitals and Clinics , Diagnostic Laboratories), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

PCOS is a hormonal disorder that affects 1 in 10 women of childbearing age. It can cause irregular periods, trouble getting pregnant, and hair growth on the face and body. This condition results in irregular menstrual cycles, abnormal ovulation, high androgen levels, enlarged ovaries, and insulin resistance. It has been found to affect 5 million women of reproductive age. It also causes serious complications such as infertility, rheumatoid arthritis, high blood pressure, heart disease, and diabetes.

Market Dynamics:

Surging cases of PCOS condition and increased awareness among women about its symptoms is expected to drive growth of the global PCOS diagnostic market over the forecast period. Other factors including obesity, sedentary lifestyle, and hormonal disorders are also expected to drive the market’s growth.

However, stringent regulatory approval processes for PCOS disease drugs and side effect of treatment drugs are expected to hinder growth of the global PCOS diagnostic market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global PCOS diagnostic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global PCOS diagnostic market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Quest Diagnostics Incorporated, LabCorp, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., IGENOMIX, The Cooper Companies, Inc., Ansh Labs, LLC, Beckman Coulter, Inc., BioVendor - Laboratorní Medicína a.s., and SRL Diagnostics, Core Diagnostics

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global PCOS diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PCOS diagnostic market

Detailed Segmentation:

PCOS Diagnostic Market, By Diagnostic Test Type:

Hormone Level Testing

Ultrasound Imaging

Blood Glucose and Insulin Testing

Lipid Profile Testing

Pelvic Examination

Genetic Testing

Other Diagnostic Tests

PCOS Diagnostic Market, By Endocrine Profile:

Androgen Excess

Hyperinsulinemia

Elevated LH (Luteinizing Hormone) Levels

Irregular Menstrual Cycles

Elevated Estrogen Levels

Other Endocrine Profile Markers

PCOS Diagnostic Market, By Symptom-Based Classification:

Hyperandrogenism

Menstrual Irregularities

Polycystic Ovaries on Ultrasound

Other Clinical Symptoms

PCOS Diagnostic Market, By Age Group:

Adolescent (Pediatric)

Adult

PCOS Diagnostic Market, By Diagnostic Setting:

Hospitals

Clinics and Diagnostic Centers

Research Institutes

Home-based Testing

PCOS Diagnostic Market, By Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Company Profile:

Quest Diagnostics Incorporated

LabCorp

F. Hoffmann-La Roche Ltd.

Siemens Healthineers AG

Abbott Laboratories

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

IGENOMIX

The Cooper Companies, Inc.

Ansh Labs, LLC

Beckman Coulter, Inc.

BioVendor - Laboratorní Medicína a.s.

SRL Diagnostics

Core Diagnostics

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market PCOS Diagnostic, By Diagnostic Test Type; Market PCOS Diagnostic, By Endocrine Profile; Market PCOS Diagnostic, By Symptom-Based Classification; Market PCOS Diagnostic, By Age Group; Market PCOS Diagnostic, By Diagnostic Setting; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Surging cases of PCOS condition; Increased awareness among women about its symptoms; Restraints; Side Effects of Drugs; Lack of FDA Approved Drugs Specific to Polycystic Ovarian Syndrome; Opportunities; Growing awareness about polycystic ovarian syndrome treatment; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. PCOS Diagnostic Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. PCOS Diagnostic Market , By Diagnostic Test Type, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023 – 2030; Segment Trends; Hormone Level Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Ultrasound Imaging; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Blood Glucose and Insulin Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Lipid Profile Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Pelvic Examination; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Genetic Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Other Diagnostic Tests; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. PCOS Diagnostic Market , By Endocrine Profile, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Androgen Excess; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Hyperinsulinemia; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Elevated LH (Luteinizing Hormone) Levels; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Irregular Menstrual Cycles; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Elevated Estrogen Levels; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Other Endocrine Profile Markers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
7. PCOS Diagnostic Market , By Symptom-Based Classification, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Hyperandrogenism; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Menstrual Irregularities; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Polycystic Ovaries on Ultrasound; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Other Clinical Symptoms; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
8. PCOS Diagnostic Market , By Age Group, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Adolescent (Pediatric); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Adult; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
9. PCOS Diagnostic Market , By Diagnostic Setting, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Clinics and Diagnostic Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Research Institutes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); Home-based Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion); 10. PCOS Diagnostic Market , By Region, 2018-2030, (US$ Bn); Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2023–2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Endocrine Profile, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Symptom-Based Classification, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Setting, 2018-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Endocrine Profile, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Symptom-Based Classification, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Setting, 2018-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Endocrine Profile, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Symptom-Based Classification, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Setting, 2018-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Endocrine Profile, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Symptom-Based Classification, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Setting, 2018-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Endocrine Profile, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Symptom-Based Classification, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Setting, 2018-2030,(US$ Bn); 11. Competitive Landscape; Quest Diagnostics Incorporated; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; LabCorp; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; F. Hoffmann-La Roche Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Siemens Healthineers AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Abbott Laboratories; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Thermo Fisher Scientific Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Bio-Rad Laboratories, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Agilent Technologies, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; IGENOMIX; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; The Cooper Companies, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Analyst Views; 12. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on “PCOS Diagnostic Market” - Global forecast to 2030